Senestech Supply Chain
Supply Chain of Senestech (SNES) as of Oct 28, 2026.
Get this data via API
Financial Data API
Supply Chain
-
Last updated:
Supply chains in stock corporations are essential components of business infrastructure and play a crucial role in value creation and competitiveness. These supply chains encompass all steps from raw material procurement and production to the delivery of finished products to the end customer.
Senestech Supply Chain
Correlation: how closely stock prices move together
Same directionNo relationOpposite
1 companies
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.14 | 0.18 | -0.46 |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Senestech Stock analysis
What does Senestech do? SenesTech, Inc. generates revenue through the sale of ContraPest, a fertility control product targeting rat populations in the pest control industry. ContraPest disrupts reproductive systems in both male and female rats, leading to contraception and eventual sterility. The company's pipeline includes feral animal fertility control for managing feral dogs and hogs in population management, non-surgical spay and neutering for companion dogs and cats in the companion animal health segment, and boar taint solutions for boars in food production and safety. These products are sold to pest control companies, animal health providers, and agricultural businesses.
ContraPest is the primary revenue driver, with its application in pest control targeting rat populations. The feral animal fertility control product addresses population management needs for feral dogs and hogs, while non-surgical spay and neutering caters to companion animal health providers. Boar taint solutions are directed at food production companies seeking to improve safety and quality by addressing boar taint in boars. The company's focus on fertility control across multiple segments allows it to serve diverse clients within pest control, animal health, and food production sectors.
SenesTech's revenue streams are derived from the commercialization of ContraPest and its pipeline products. ContraPest is sold to pest control businesses for managing rat infestations, while feral animal fertility control is marketed to organizations involved in managing feral animal populations. Non-surgical spay and neutering products target veterinary clinics and pet care providers, and boar taint solutions are sold to food production companies. The company's business model centers on providing fertility control solutions tailored to specific industry needs. Senestech is one of the most popular companies on Eulerpool.
All Key Metrics — Senestech
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth